0615-1511 : Acetazolamide 250 mg Oral Tablet


NDC0615-1511
Labeler: Ncs Healthcare of Ky, Inc Dba Vangard Labs
Product Type: Human Prescription Drug
Drug Name:  Acetazolamide
Dosage Form: Oral Tablet
Application #: ANDA040195
Rev. Date: 


Appearance:


Markings: T53
Shapes:  Round
Colors:  White
Size (mm): 11
Segments: * 4

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 4 indicates a scored pill which can be broken into 4 equal pieces.

T53: (51672-4023) Acetazolamide 250 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0615-1511-39: 30 TABLET IN 1 BLISTER PACK (0615‑1511‑39)

Active Ingredients:

  • Acetazolamide

Dosage Strength:

  • 250 mg

Inactive Ingredients:

  • Lactose Monohydrate
  • Starch, Corn
  • Gelatin
  • Glycerin
  • Water
  • Talc
  • Sodium Starch Glycolate Type a Potato
  • Magnesium Stearate

Pharmaceutical Classes:

  • Carbonic Anhydrase Inhibitor [EPC]
  • Carbonic Anhydrase Inhibitors [MoA]
  • Sulfonamides [CS]

Related Products:

Based on records with the same trade name.
  • 0143-9503 Acetazolamide 500 mg Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0179-0050 Acetazolamide 500 mg 12 Hr Extended Release Capsule by Kaiser Foundation Hospitals
  • 0527-1050 Acetazolamide 250 mg Oral Tablet by Lannett Company, Inc.
  • 0555-0513 Acetazolamide 500 mg 12 Hr Extended Release Capsule by Barr Laboratories Inc..
  • 0904-6663 Acetazolamide 250 mg Oral Tablet by Major Pharmaceuticals
  • 10135-567 Acetazolamide 250 mg Oral Tablet by Marlex Pharmaceuticals Inc
  • 23155-120 Acetazolamide 500 mg 12 Hr Extended Release Capsule by Heritage Pharmaceuticals Inc.
  • 23155-287 Acetazolamide 125 mg Oral Tablet by Heritage Pharmaceuticals Inc.
  • 23155-288 Acetazolamide 250 mg Oral Tablet by Heritage Pharmaceuticals Inc.
  • 23155-313 Acetazolamide 500 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Heritage Pharmaceuticals Inc.
  • 25021-817 Acetazolamide 500 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 29033-030 Acetazolamide 500 mg Oral Capsule, Extended Release by Nostrum Laboratories, Inc.
  • 39822-0190 Acetazolamide 500 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by X-gen Pharmaceuticals, Inc.
  • 39822-0191 Acetazolamide 500 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by X-gen Pharmaceuticals, Inc.
  • 42291-089 Acetazolamide 125 mg Oral Tablet by Avkare, Inc.
  • 42291-090 Acetazolamide 250 mg Oral Tablet by Avkare, Inc.
  • 42291-103 Acetazolamide 250 mg Oral Tablet by Avkare, Inc.
  • 46708-349 Acetazolamide 500 mg Oral Capsule, Extended Release by Alembic Pharmaceuticals Limited
  • 50090-0279 Acetazolamide 250 mg Oral Tablet by A-s Medication Solutions
  • 50090-0577 Acetazolamide 125 mg Oral Tablet by A-s Medication Solutions
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0615-1511 QR Code

< Prev: 0615-1504Next: 0615-1516 >

Related Discussions:

Acetazolamide (Diamox)
What are the main side effects of Diamox (Acetazolamide) Slow Release Tablets? ## Hello, D. Thomas! How are you? And at ... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA